For the millions of patients with Parkinson disease psychosis, the first agent in a new class of drugs may offer some relief from hallucinations and delusions while easing the challenges that caregivers face. More than half of the 7 million… Read More ›
As we all now know, the start-up of the federally run insurance exchange websites and the first few weeks that the exchanges have been operating have been extremely bumpy—certainly bumpier than anyone (including me) had been predicting. The experience of… Read More ›
Older teenagers and young adults diagnosed with cancer may be at increased risk of suicide, especially in the first year after their diagnosis, according to findings published today in the Annals of Oncology. A population-based cohort study conducted by researchers… Read More ›
The US Food and Drug Administration (FDA) has created fast-track approval processes to speed certain drugs to market, but an analysis of these expedited approvals finds they often leave important safety questions unanswered. The analysis was published today in JAMA… Read More ›
The eradication of polio is within the world’s grasp in the next 5 years, according to the world’s leading expert on polio. Bruce Aylward, MD, MPH, assistant director-general for polio, emergencies, and country collaboration of the World Health Organization, made… Read More ›
The sleeping giant of HIV infection—a reservoir of viral DNA that lies dormant in human immune cells—could be far larger than previously believed. A study published today in the journal Cell shows that the reservoir, consisting of proviruses integrated into… Read More ›
For many people, getting a seasonal flu shot may help them avoid a week or more of misery. But for some individuals, especially those with heart disease, vaccination against influenza appears to help reduce the likelihood of major adverse cardiovascular… Read More ›
